Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a random

Trelagliptin is a novel once-weekly oral DPP-4 inhibitor. We assessed the efficacy and safety of trelagliptin versus the daily oral DPP-4 inhibitor alogliptin i ... In the primary analysis, the least squares mean change in HbA 1c concentration from baseli...

搭捷運

晚上十一點多，看到這位姊姊與你一起搭捷運，不知道做何感想？...

大嬸的絕技，小朋友別亂學！ 稳稳低 . . . .

大嬸的絕技，小朋友別亂學！ 稳稳低 . . . ....

使用電腦需知

  你知道麼嗎？保護自己的隱私是很重要的事情！...

沒看過這麼敷衍的運動員

你可以在敷衍一點沒關係!...